Basho Chandan, the Chief Operating Officer and Chief Financial Officer of Astrana Health, Inc., has reported a recent transaction involving the surrender of shares. This filing, dated October 6, 2026, reveals that Chandan surrendered 2,092 shares to offset tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026.
This transaction is significant as it underscores the ongoing adjustments in executive compensation strategies within the management consulting services sector. As companies like Astrana Health navigate the complexities of compensation and taxation, such moves by executives can reflect broader trends in how equity is managed.
Background
Astrana Health, Inc. operates under the management consulting services classification. The company is incorporated in Delaware and is recognized for its strategic focus in the healthcare sector. The recent filing is part of a series of Form 4 submissions, with the latest transactions indicating a pattern of share management by its executives.
What the Filing Says
The filing details that Chandan's transaction involved the surrender of shares to meet tax obligations. Following this transaction, he now holds a total of 155,728 shares, which includes 15,202 shares of unvested restricted stock. These unvested shares are set to vest on May 16, 2027, contingent on his continued employment with the company.
Impact
This transaction may affect Astrana Health's executive compensation landscape, as it highlights the need for executives to manage their equity holdings in light of tax implications. The management consulting services industry, represented by Astrana Health, is likely to see similar trends as companies adjust their compensation structures in response to tax regulations.
What's Next
The filing does not say what happens next.